RESUMEN
Consensus on Science and Treatment recommendations aim to balance the benefits of early resuscitation with the potential for harm to care providers during the COVID-19 pandemic. Chest compressions and cardiopulmonary resuscitation have the potential to generate aerosols. During the current COVID-19 pandemic lay rescuers should consider compressions and public-access defibrillation. Lay rescuers who are willing, trained and able to do so, should consider providing rescue breaths to infants and children in addition to chest compressions. Healthcare professionals should use personal protective equipment for aerosol generating procedures during resuscitation and may consider defibrillation before donning personal protective equipment for aerosol generating procedures.
Asunto(s)
Reanimación Cardiopulmonar/normas , Infecciones por Coronavirus/terapia , Paro Cardíaco/terapia , Pandemias/estadística & datos numéricos , Neumonía Viral/terapia , Guías de Práctica Clínica como Asunto , Comités Consultivos , COVID-19 , Reanimación Cardiopulmonar/tendencias , Consenso , Infecciones por Coronavirus/epidemiología , Enfermedad Crítica/terapia , Desfibriladores/estadística & datos numéricos , Femenino , Salud Global , Humanos , Internacionalidad , Masculino , Evaluación de Necesidades , Pandemias/prevención & control , Neumonía Viral/epidemiología , Análisis de SupervivenciaRESUMEN
The aim of the present study was to determine if elevations in salt intake were coupled to increases in renal alpha 2-adrenergic receptors in SHR that differ in their blood pressure response to high salt diets. Salt-resistant spontaneously hypertensive rats (SHR-R), which do not increase their blood pressure in response to high salt intake, and salt-sensitive spontaneously hypertensive rats (SHR-S), which do exhibit significant elevations in blood pressure on high salt diets (3.15% NaCl), were used. Radioligand binding studies using [3H]rauwolscine were performed on 6- and 11-week-old SHR-S and Wistar-Kyoto (WKY) rats to determine the effects of age, strain, and salt intake on alpha 2-adrenergic receptor number and affinity. One week of high salt intake significantly increased blood pressure 22% in 6-week-old SHR-S and increased the blood pressure of 11-week-old SHR-S 12% without altering WKY rat controls. This treatment did not significantly increase renal alpha 2-adrenergic receptors in either SHR-S or WKY rats. SHR-S had significantly higher numbers of renal alpha 2-adrenergic receptors than WKY rats on the high salt diets. One week of high (3.15%) or low (0.05%) salt intake did not significantly alter renal alpha 2-adrenergic receptor number in 11-week-old SHR-S or WKY rats; however, blood pressure was significantly elevated in the SHR-S (175.0 +/- 3.5 versus 196.0 +/- 3.0 mm Hg).(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Presión Sanguínea/fisiología , Hipertensión/fisiopatología , Receptores Adrenérgicos alfa/fisiología , Cloruro de Sodio/farmacología , Animales , Presión Sanguínea/efectos de los fármacos , Riñón/análisis , Riñón/fisiología , Norepinefrina/análisis , Ratas , Ratas Endogámicas SHR , Regulación hacia ArribaRESUMEN
OBJECTIVE: To evaluate the utility of bilevel positive airway pressure (BiPAP) in the out-of-hospital treatment of patients with presumed congestive heart failure (CHF). METHODS: This was a prospective, sequential, parallel trial in an urban setting served by a single emergency medical services (EMS) system between January 4 and April 15, 1999. A convenience sampling of adults who were transported by rescue units judged to be in CHF by treating emergency medical technicians trained in advanced life support (ALS EMTs) was included. Rescue squads were divided into demographically matched pairs, and one of each was equipped with a BiPAP ventilatory support unit. Bilevel positive airway pressure therapy was added to the existing treatment protocols for eligible study patients. Main outcome measures were out-of-hospital treatment time, oxygen saturation changes, hospitalization length, need for endotracheal intubation, mortality rate, and ease of use of the device by EMS personnel. RESULTS: Sixty-two of 71 enrolled patients completed the study. Out-of-hospital treatment times did not differ between groups (31.2 minutes vs 31.4 minutes; p = 0.931). The difference between pre- and post-treatment oxygen saturation levels was greater for the BiPAP group (13.71%) than the control group (6.69%) (p < 0.05). There was no statistical difference between groups in the length of hospital stay [control: 7.63 days, vs BiPAP: 6.33 days, p = 0.48], the intubation rate [control: 7 of 25 (28%) vs BiPAP: 4 of 37 (11%), p = 0.10], or death rate [control: 2 of 24, vs BiPAP: 6 of 37, p = 0.46]. All of the ALS EMTs who used BiPAP thought that it was safe to use, and 97% thought it was easy and appeared to improve patients' dyspnea and respiratory distress. CONCLUSIONS: ALS EMTs can be trained to deliver noninvasive ventilation with BiPAP, find it easy to apply, and believe that it helps relieve dyspnea in patients with suspected CHF.